QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
OTCMKTS:AMAR

Amarillo Biosciences - AMAR Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
$0.21
$3.24
52-Week Range
N/A
Volume
195,623 shs
Average Volume
18,253 shs
Market Capitalization
$136.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AMAR stock logo

About Amarillo Biosciences (OTCMKTS:AMAR) Stock

Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.

Receive AMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AMAR Stock News Headlines

AbraSilver Resource Corp (ABRA)
See More Headlines

Receive AMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AMAR Company Calendar

Last Earnings
11/14/2018
Today
8/11/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AMAR
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Net Income
$-1,450,000.00
Net Margins
-41,453.98%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20,000.00
Book Value
($0.03) per share

Miscellaneous

Free Float
N/A
Market Cap
$136.29 million
Optionable
Not Optionable
Beta
-0.06

Key Executives

  • Dr. Stephen T. Chen (Age 71)
    Chairman, CEO, Pres, CFO & COO
    Comp: $340.98k
  • Mr. Bernard Cohen (Age 68)
    VP of Admin.
    Comp: $83.08k
  • Mr. John Junyong Lee Esq.
    Chief Legal Counsel & Sec.













AMAR Stock - Frequently Asked Questions

How have AMAR shares performed in 2022?

Amarillo Biosciences' stock was trading at $0.84 at the beginning of the year. Since then, AMAR shares have increased by 285.7% and is now trading at $3.24.
View the best growth stocks for 2022 here
.

How were Amarillo Biosciences' earnings last quarter?

Amarillo Biosciences, Inc. (OTCMKTS:AMAR) released its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm earned $0.02 million during the quarter.

What other stocks do shareholders of Amarillo Biosciences own?

What is Amarillo Biosciences' stock symbol?

Amarillo Biosciences trades on the OTCMKTS under the ticker symbol "AMAR."

How do I buy shares of Amarillo Biosciences?

Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Amarillo Biosciences' stock price today?

One share of AMAR stock can currently be purchased for approximately $3.24.

How much money does Amarillo Biosciences make?

Amarillo Biosciences (OTCMKTS:AMAR) has a market capitalization of $136.29 million and generates $20,000.00 in revenue each year.

How can I contact Amarillo Biosciences?

Amarillo Biosciences' mailing address is 4134 BUSINESS PARK DRIVE, AMARILLO TX, 79110. The official website for the company is www.amarbio.com. The company can be reached via phone at 806-376-1741 or via email at abi@amarbio.com.

This page (OTCMKTS:AMAR) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.